US Stock MarketDetailed Quotes

ALT Altimmune

Watchlist
  • 8.250
  • +0.070+0.86%
Close Dec 20 16:00 ET
  • 8.400
  • +0.150+1.82%
Post 19:56 ET
586.78MMarket Cap-5.25P/E (TTM)

Altimmune Key Stats

Altimmune Q3 2024 Earnings Date

Currency:USDNov 12, 2024

Estimate
(YoY)
Actual
(YoY)
Vs Estimate
(% Chg)
Revenue
620.00
5.00K
+4.38K
Beat Est.
-99.83%
-98.62%
+706.45%
EPS
-0.36
-0.32
+0.04
Beat Est.
+7.95%
+17.95%
+10.84%
Strong Buy

Dec 3, 2024

Altimmune Earnings Estimates

Revenue

EPS

EBIT

Revenue is based on 5 analyst forecasts. Estimate data is from S&P, and actual data is from Income Statement

Currency: USD

Actual
Estimate
DatePeriodRevenue/EstimateEarnings Call
--2025/Q1-- / 1.000K--
--2024/Q4-- / 0.000--
Nov 12, 20242024/Q35.000K / 620.000--
Aug 8, 20242024/Q25.000K / 620.000--
May 9, 20242024/Q15.000K / 0.000--
DatePeriodRevenue/EstimateEarnings Call
--2025/Q1-- / 1.000K--
--2024/Q4-- / 0.000--
Nov 12, 20242024/Q35.000K / 620.000--
Aug 8, 20242024/Q25.000K / 620.000--
May 9, 20242024/Q15.000K / 0.000--

Unlock Free Earnings Estimates

Altimmune Earnings Reports

Read more

Trending US Stocks
Fed Rate Cut Beneficiaries Fed Rate Cut Beneficiaries

Stocks that are expected to benefit from a Federal Reserve rate cut. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only. This section presents the top 5 stocks in Fed Rate Cut Beneficiaries, ranked from highest to lowest based on real-time market data. Stocks that are expected to benefit from a Federal Reserve rate cut. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only. This section presents the top 5 stocks in Fed Rate Cut Beneficiaries, ranked from highest to lowest based on real-time market data.

Analysis

Analyst Rating

Updated: Dec 3, 2024

Strong Buy

  • Buy

    100.00%
  • Hold

    0.00%
  • Sell

    0.00%

Price Target

No Data